There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Erdosteine, a drug approved for the treatment of acute and chronic pulmonary diseases,
has been shown to be an effective treatment for chronic bronchitis or COPD (CB/COPD)
in several studies, although marked differences in the perception of its usefulness
still remain.